640 results
-
List item
Committee for Advanced Therapies (CAT): 12-14 July 2023 (updated)
European Medicines Agency, Amsterdam, the Netherlands, from 12/07/2023 to 14/07/2023, Last updated: 19/09/2023 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 5-8 June 2023 (updated)
European Medicines Agency, Amsterdam, the Netherlands, from 05/06/2023 to 08/06/2023, Last updated: 04/09/2023 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 10-12 May 2023 (updated)
European Medicines Agency, Amsterdam, the Netherlands, from 10/05/2023 to 12/05/2023, Last updated: 31/08/2023 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 28-31 August 2023 (updated)
European Medicines Agency, Amsterdam, the Netherlands, from 28/08/2023 to 31/08/2023, Last updated: 28/08/2023 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 11-14 April 2023
European Medicines Agency, Amsterdam, the Netherlands, from 11/04/2023 to 14/04/2023, Last updated: 07/07/2023 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 3-6 July 2023
European Medicines Agency, Amsterdam, the Netherlands, from 03/07/2023 to 06/07/2023, Last updated: 07/07/2023 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 13-16 March 2023
European Medicines Agency, Amsterdam, the Netherlands, from 13/03/2023 to 16/03/2023, Last updated: 22/06/2023 -
List item
Committee for Advanced Therapies (CAT): 15 June 2023
European Medicines Agency, Amsterdam, the Netherlands, 15/06/2023, Last updated: 15/06/2023 -
List item
Committee for Advanced Therapies (CAT): 19-21 April 2023
European Medicines Agency, Amsterdam, the Netherlands, from 19/04/2023 to 21/04/2023, Last updated: 12/06/2023 -
List item
Committee for Advanced Therapies (CAT): 22-23 March 2023
European Medicines Agency, Amsterdam, the Netherlands, from 22/03/2023 to 23/03/2023, Last updated: 12/06/2023 -
List item
News: Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 10 - 12 May 2023
PRAC, Last updated: 22/05/2023 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 6-9 February 2023
European Medicines Agency, Amsterdam, the Netherlands, from 06/02/2023 to 09/02/2023, Last updated: 17/05/2023 -
List item
Committee for Advanced Therapies (CAT): 15-17 May 2023
European Medicines Agency, Amsterdam, the Netherlands, from 15/05/2023 to 17/05/2023, Last updated: 15/05/2023 -
List item
Committee for Advanced Therapies (CAT): 15-17 February 2023
European Medicines Agency, Amsterdam, the Netherlands, from 15/02/2023 to 17/02/2023, Last updated: 18/04/2023 -
List item
Committee for Advanced Therapies (CAT): 18-19 January 2023
European Medicines Agency, Amsterdam, the Netherlands, from 18/01/2023 to 19/01/2023, Last updated: 18/04/2023 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 28 November - 1 December 2022
European Medicines Agency, Amsterdam, the Netherlands, from 28/11/2022 to 01/12/2022, Last updated: 03/04/2023 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 4-7 July 2022
European Medicines Agency, Amsterdam, the Netherlands, from 04/07/2022 to 07/07/2022, Last updated: 31/03/2023 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 24-27 October 2022
European Medicines Agency, Amsterdam, the Netherlands, from 24/10/2022 to 27/10/2022, Last updated: 31/03/2023 -
List item
Committee for Advanced Therapies (CAT): 7-9 December 2022
European Medicines Agency, Amsterdam, the Netherlands, from 07/12/2022 to 09/12/2022, Last updated: 08/02/2023 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 2-5 May 2022
European Medicines Agency, Amsterdam, the Netherlands, from 02/05/2022 to 05/05/2022, Last updated: 06/02/2023 -
List item
Committee for Advanced Therapies (CAT): 3-4 November 2022
European Medicines Agency, Amsterdam, the Netherlands, from 03/11/2022 to 04/11/2022, Last updated: 21/12/2022 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 7-10 March 2022
European Medicines Agency, Amsterdam, the Netherlands, from 07/03/2022 to 10/03/2022, Last updated: 22/11/2022 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 7-10 February 2022
European Medicines Agency, Amsterdam, the Netherlands, from 07/02/2022 to 10/02/2022, Last updated: 07/11/2022 -
List item
News: EMA recommends measures to minimise risk of serious side effects with Janus kinase inhibitors for chronic inflammatory disorders
PRAC, Last updated: 03/11/2022 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 10-13 January 2022
European Medicines Agency, Amsterdam, the Netherlands, from 10/01/2022 to 13/01/2022, Last updated: 07/10/2022